These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2951075)

  • 1. The biological properties of insulins with tyrosine replaced by phenylalanine at positions 14 and 19 of the A chain.
    Cockram CS; Jones RH; Sönksen PH
    Diabet Med; 1985 Jul; 2(4):241-4. PubMed ID: 2951075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
    Chu YC; Zong L; Burke GT; Katsoyannis PG
    J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An examination of the role of insulin dimerisation and negative cooperativity using the biological properties of the despentapeptide and deshexapeptide insulins.
    Cockram CS; Jones RH; Sonksen PH; Tatnell MA; Zhu SQ; Dodson G
    Diabetologia; 1987 Sep; 30(9):733-8. PubMed ID: 3322916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin analogues with modifications at position B26. Divergence of binding affinity and biological activity.
    Záková L; Kazdová L; Hanclová I; Protivínská E; Sanda M; Budesínský M; Jirácek J
    Biochemistry; 2008 May; 47(21):5858-68. PubMed ID: 18452310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of the insulin receptor in vivo in rabbits and its possible role as a reservoir for the plasma hormone.
    Zeleznik AJ; Roth J
    J Clin Invest; 1978 May; 61(5):1363-74. PubMed ID: 659598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel insulin derivative chemically modified with dehydrocholic acid: synthesis, characterization and biological activity.
    Huang T; Huang K
    Biotechnol Appl Biochem; 2005 Aug; 42(Pt 1):47-56. PubMed ID: 15612881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Pharmacodynamics of chemically modified insulins.
    Jones RH; Dron DI; Ellis MJ; Sönksen PH
    J Endocrinol; 1975 Jun; 65(3):58P. PubMed ID: 1151257
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the relationship between the molecular structure and the catabolism of insulin.
    Papachristodoulou D; Brandenburg D; Dron DI; Jones RH; Sönksen PH; Thomas JH
    Acta Biol Med Ger; 1977; 36(11-12):1705-12. PubMed ID: 616716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action.
    Frick W; Bauer A; Bauer J; Wied S; Müller G
    Biochemistry; 1998 Sep; 37(38):13421-36. PubMed ID: 9748349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B9-serine residue is crucial for insulin actions in glucose metabolism.
    Liao ZY; Tang YH; Xu MH; Feng YM; Zhu SQ
    Acta Pharmacol Sin; 2001 Oct; 22(10):939-43. PubMed ID: 11749779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (A14-phenylalanine)insulin: a new synthetic analogue.
    Danho W; Sasaki A; Büllesbach E; Gattner HG; Wollmer A
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):747-54. PubMed ID: 7000657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-assisted semisynthesis of shortened B26-modified insulins.
    Sievert D; Gattner HG; Lenz V; Höcker H
    Biomed Biochim Acta; 1991; 50(10-11):S197-200. PubMed ID: 1820045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
    Ohta N; Burke GT; Katsoyannis PG
    J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of placement of tryptophan residues in selected A-chain positions on the biological profile of insulin.
    Chu YC; Burke GT; Ross JB; Katsoyannis PG
    J Protein Chem; 1993 Aug; 12(4):499-505. PubMed ID: 8251071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats.
    Philippe J; Halban PA; Gjinovci A; Duckworth WC; Estreicher J; Renold AE
    J Clin Invest; 1981 Mar; 67(3):673-80. PubMed ID: 6451633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for separate handling in vivo of different regions of the insulin molecule using A14- and B1-labeled insulin tracers.
    Cockram CS; Jones RH; Boroujerdi MA; Sönksen PH
    Diabetes; 1984 Aug; 33(8):721-7. PubMed ID: 6378697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (A1-phenylalanine) insulin: a new synthetic analogue.
    Danho W; Sasaki A; Büllesbach E; Föhles J; Gattner HG
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):735-46. PubMed ID: 7000656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine and human insulin (Novo): a comparison of their metabolism and hypoglycemic activity in normal man.
    Adeniyi-Jones RO; Jones RH; Barnes DG; Gerlis LS; Sönksen PH
    Diabetes Care; 1983; 6 Suppl 1():9-12. PubMed ID: 6343043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of new hypoglycemic agent A-4166 on lipolysis and lipogenesis in rat adipocytes.
    Macho L; Fickova M; Zorad S; Sebokova E; Klimes I
    Endocr Regul; 2000 Sep; 34(3):119-26. PubMed ID: 11074662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.